Neurosense Therapeutics is trading at $0.50 (5% up) in after-hours trading as bargain hunters step in following a period of sharp declines.
- The move extends a rebound that began during the regular session, following several days of weakness across the broader biotech sector.
- Market commentary highlights value-buying interest after the recent selloff rather than any new fundamental news or earnings catalysts.